Hong Kong Stock Movement | Everest Medicines (01952.HK) Rises Over 3%; Two New Drugs Included in National Reimbursement Drug List for the First Time; Velsipity Shows Favorable Safety Profile in Treating Ulcerative Colitis
Zhitong Finance APP has learned that Everest Medicines (01952.HK) rose over 3%, up 3.45% as of press time, at HK$26.42, with a turnover of HK$85.8234 million.
Latest

